Fractyl Health, Inc. (GUTS) — insider trading
Health Care · NASDAQ
Fractyl Health, Inc. (GUTS) has 14 reported SEC Form 4 insider transactions in our data, including 5 open-market purchases among the most recent 14 (latest 2026-06-12).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-12 | Royan Ajay | Director | Open-market purchase | 23,000 | $0.85 | $19.6K | Form 4 |
| 2026-06-10 | Rajagopalan Harith | Director, Officer (Chief Executive Officer) | Open-market purchase | 25,000 | $0.73 | $18.3K | Form 4 |
| 2026-06-10 | Sheffield Ian | Director | Grant / award / vesting (derivative) | 22,500 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Sheffield Ian | Director | Open-market purchase | 35,000 | $0.73 | $25.5K | Form 4 |
| 2026-06-10 | MEANWELL CLIVE | Director | Grant / award / vesting (derivative) | 22,500 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Barnes Kelly Ann | Director | Grant / award / vesting (derivative) | 22,500 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Elia Marc | Director | Grant / award / vesting (derivative) | 22,500 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Thompson Christopher Charles | Director | Grant / award / vesting (derivative) | 22,500 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Royan Ajay | Director | Grant / award / vesting (derivative) | 22,500 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Conaway Samuel | Director | Grant / award / vesting (derivative) | 22,500 | $0.00 | $0 | Form 4 |
| 2026-06-10 | BRADLEY WILLIAM | Director | Grant / award / vesting (derivative) | 22,500 | $0.00 | $0 | Form 4 |
| 2026-06-10 | BRADLEY WILLIAM | Director | Open-market purchase | 68,493 | $0.73 | $50.3K | Form 4 |
| 2026-06-08 | Smith Weber Lara | Officer (Chief Financial Officer) | Open-market purchase | 20,000 | $0.69 | $13.7K | Form 4 |
| 2026-01-12 | Smith Weber Lara | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 1,036,800 | $0.00 | $0 | Form 4 |
Ask the chat about GUTS's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Fractyl Health, Inc. (GUTS).
Last updated 2026-06-12 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.